Presentation

Reduction in Platelet Reactivity with Prasugrel 5 mg in Low-Weight Patients Is Noninferior to Prasugrel 10 mg in Higher-Weight Patients

Presenter: David Erlinge

October 17, 2012

REGISTER for free or LOG IN to view this content

Reduction in Platelet Reactivity with Prasugrel 5 mg in Low-Weight Patients Is Noninferior to Prasugrel 10 mg in Higher-Weight Patients

CAD Pharma

Factoid

Up Next

Presentation

Cost-Effectiveness of TAVR vs. Surgical Aortic Valve Replacement in High-Risk Patients with Severe Aortic Stenosis

Presenter: M.R. Reynolds

November 08, 2012

More slides +

Presentation TCT 2015

CardiAQ: Novel Design Features and Clinical Updates

Presenter: Gian Paolo Ussia

October 12, 2015

Presentation TCT 2015

Device and Clinical Program Highlights: Inspiron

Presenter: Pedro A. Lemos

October 12, 2015

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.